Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.03.24 | Recce Pharmaceuticals - R&D advance (A$11.18m) extends runway | 197 | Edison Investment Research | Recce Pharmaceuticals recently received A$11.18m as an R&D advance credit through an arrangement with Endpoints Capital for the R&D tax credit rebates that Recce expects to receive for FY23/FY24 and... ► Artikel lesen | |
26.03.24 | Immix Biopharma - Marching towards US clinical trials for NXC-201 | 346 | Edison Investment Research | Immix Biopharma is closer to dosing its first US patient for lead CAR-T asset NXC-201, with the appointment of the Memorial Sloan Kettering Cancer Center as the main clinical site for the company's... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 2.962 |
TESLA | 2.163 |
STEYR MOTORS | 2.131 |
DEUTZ | 1.997 |
RENK GROUP | 1.910 |
TUI | 1.799 |
THYSSENKRUPP | 1.591 |
RHEINMETALL | 1.568 |
NEL | 1.449 |
BYD | 1.435 |
BAYER | 1.129 |
EVOTEC | 999 |
NOVO NORDISK | 987 |
DEUTSCHE BANK | 887 |
XIAOMI | 862 |
COMMERZBANK | 797 |
BASF | 794 |
VOLKSWAGEN | 781 |
MERCEDES-BENZ | 724 |
AIXTRON SE | 695 |
PUMA | 677 |
PORSCHE AG | 675 |
HENSOLDT | 652 |
BARRICK GOLD | 636 |
MUTARES | 636 |